UK markets closed

ageas SA/NV (0Q99.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
46.42-1.49 (-3.10%)
At close: 6:24PM GMT
Full screen
Previous close47.90
Bid45.85 x 0
Ask47.01 x 0
Day's range45.19 - 46.92
52-week range38.61 - 53.96
Avg. volume167,877
Market cap8.637B
Beta (5Y monthly)0.86
PE ratio (TTM)12.16
EPS (TTM)3.82
Earnings dateN/A
Forward dividend & yield5.03 (10.84%)
Ex-dividend date02 Jun 2021
1y target estN/A
  • Globe Newswire

    Ageas reports on the progress of share buy-back programme

    Further to the initiation of the share buy-back programme announced on 11 August 2021, Ageas reports the purchase of 21,041 Ageas shares in the period from 15-11-2021 until 19-11-2021. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)15-11-20214,691200,54442.7542.0243.4616-11-20214,300193,74745.0643.8545.5517-11-20214,000180,84245.2144.7746.1218-11-20213,852180,03746.7445.7347.8919-11-20214,198197,50847.0546.8247.69Total21,041952,67845.2842.0247.89 Since t

  • Globe Newswire

    Ageas and Schroders plc: Transparency notification

    Ageas and Schroders plc: Transparency notification In accordance with the rules on financial transparency*, Schroders plc has notified Ageas on 16 November 2021 that, on 15 November 2021, its interest has exceeded the statutory threshold of 3% of the shares issued by Ageas. Its current shareholding stands at 3.02%. Reason for the notificationAcquisition or disposal of voting securities or voting rights Notification byA parent undertaking or a controlling person Persons subject to the notificatio

  • Globe Newswire

    Ageas reports on its nine month results 2021

    Ageas reports on its nine month results 2021 Continued strong commercial performance across the businessExcellent operating performance in both Life and Non-LifeOn track to reach 2021 profit guidance and Connect21 targets Net Result The Group net result was EUR 568 million driven by an excellent performance in Life, but hampered by RPN(i)Insurance net result increased from EUR 737 million to EUR 777 millionNet result in Non-Life amounted to EUR 236 million compared to EUR 311 million in last yea